Company Data
Aptose Biosciences Inc.
Ticker
APTO
Current Price
$0.1621 -14.68%
Market Cap
$9.8M
Price Target
Refer to Report
Volume
8.7M
52wk Range
$0.13 - $2.01
Overview
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.